VISICORT

Improving the Success Rate of Corneal Transplants

VISICORT

Improving the Success Rate of Corneal Transplants

WELCOME TO VISICORT

Improving the Success Rate of Corneal Transplants


Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups. 

  • VISICORT is an EU-funded research project to help improve corneal transplant success.
  • VISICORT has collected and analyzed more than 50,000 human bio-samples from 5 leading European eye hospitals and clinics.
  • The VISICORT Foundation Biobank of bio-specimens will support future research in eye damage and disease.
  • VISICORT has manufactured a mesenchymal stromal cell product that will be trialled in people under-going high-risk corneal transplantation at the Charité University Hospital in Berlin as part of a safety and feasibility study to mitigate rejection episodes.



Follow @visicort on twitter.



Project Partners